Commentary on an article by Rick Delamarter, MD, et al.: "Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level degenerative lumbar disc disease. Results at twenty-four months". [electronic resource]
- The Journal of bone and joint surgery. American volume Apr 2011
- e41 p. digital
Publication Type: Comment; Journal Article
1535-1386
10.2106/JBJS.J.01847 doi
Arthroplasty, Replacement--instrumentation Device Approval Disability Evaluation Humans Intervertebral Disc Intervertebral Disc Degeneration--complications Low Back Pain--etiology Lumbar Vertebrae--surgery Multicenter Studies as Topic Patient Satisfaction Postoperative Complications Prostheses and Implants Prosthesis Design Randomized Controlled Trials as Topic Range of Motion, Articular Recovery of Function Spinal Fusion--instrumentation United States United States Food and Drug Administration